Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, BFA

Understanding Health Risks Through Affordable At-Home Genetic Testing


BURLINGAME, Calif., May 23, 2018 /PRNewswire/ -- Color is a health services company whose mission is to help everyone lead the healthiest life that technology and medicine allow. The company's clinical-grade genetic tests focus on genetic mutations that can cause serious hereditary health conditions like cancer and heart disease. With an understanding of your genetic risk, you can work with your healthcare provider to create a plan to help detect, treat, or prevent the conditions altogether.

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/83001241-color-genetic-tests/

Color Genetic Test Kit

Color's physician-ordered tests can be completed by providing a simple saliva sample at home, and they include complimentary access to board-certified genetic counselors. Color's CLIA-licensed and CAP-accredited lab deploys cutting-edge software engineering, robotics, and Next Generation Sequencing (NGS) technology to drive one of the most affordable and accessible clinical grade genetic testing programs available today.

Color tests include:

Color Testimonials:

Learn more at color.com

Breasts: The Owner's Manual
by Dr. Kristi Funk
is now available wherever books are sold.
www.breastmanual.com

SOURCE Color


These press releases may also interest you

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...

at 03:30
AMSilk GmbH ("AMSilk"), a global leader in advanced materials made from spider silk-based proteins, today announces the appointments of Ralph Fraundorfer and Ctibor Kohutovic to its Management Board starting immediately. Ralph Fraundorfer has been...

at 02:54
HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the Nature...

at 02:50
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany?Universitätsklinikum Tübingen...

at 02:24
Today, 23 April 2024, the subscription period in SciBase Holding AB (publ) ('SciBase' or the 'Company') rights issue of units of up to approximately SEK 15 million commences (the 'Rights Issue'). The Rights Issue was resolved by the Board of...



News published on and distributed by: